Details for 2018173111
Up to date per 02.04.2026
Actions
Details for 2018173111
Deleted
European Patent
21.11.2018 A
11.08.2021 B1
21.04.2004
US
56382804 P
23.07.2004
US
59034704 P
04.10.2004
US
61498404 P
C12N 15/62 20060101AFI20180814BHEP
Owner
Alexion Pharmaceuticals, Inc.121 Seaport Boulevard Boston, MA 02210US
Representative
No representatives present
Inventor
Crine, Philippe28 Avenue Champagne Outremont, Quebec H2V 2X1CA
Boileau, Guy7645 Malherbe Brossard,Quebec H3C 3J7CA
Lemire, Isabelle6538 44th Avenue Montreal,Quebec H1T 2P1CA
Loisel, Thomas P.4959, rue Saint-Gabriel Montreal,Quebec H8Y 1Z7CA